These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 9135470)

  • 1. Usefulness of iron colloid-enhanced MRI in differentiating experimental hepatocellular carcinoma from hyperplastic nodules in rats: analysis by microautoradiography.
    Suto Y; Kodama F
    Br J Radiol; 1996 Dec; 69(828):1139-44. PubMed ID: 9135470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between chondroitin sulfate iron colloid-enhanced MR imaging and the histological grade of hepatocellular carcinoma.
    Suto Y; Kodama F; Kamba M; Ohta Y
    Acta Radiol; 1995 Jan; 36(1):102-5. PubMed ID: 7833161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chondroitin sulfate iron colloid as MR contrast agent in differentiation between hepatocellular carcinoma and adenomatous hyperplasia.
    Suto Y; Kato T; Matsuo T; Kamba M; Shimatani Y; Ohuchi Y; Nakamura K; Ohta Y
    Acta Radiol; 1993 May; 34(3):226-9. PubMed ID: 8387803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chondroitin sulfate iron colloid-enhanced MR imaging in patients with hepatocellular carcinoma. Comparison with CT during arterial portography.
    Kamba M; Suto Y; Kato T
    Acta Radiol; 1994 Nov; 35(6):570-5. PubMed ID: 7946680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimum conditions for iron colloid enhanced fast spin echo imaging in hepatocellular carcinoma.
    Sugihara S; Suto Y; Yoshida K
    Br J Radiol; 1997 Aug; 70(836):791-7. PubMed ID: 9486042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time-course changes of contrast enhancement in iron colloid enhanced MRI in patients with hepatocellular carcinoma.
    Suto Y; Ametani M; Kamba M; Sugihara S
    Br J Radiol; 1996 Mar; 69(819):201-5. PubMed ID: 8800862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of chondroitin sulfate iron colloid as a liver specific MR contrast agent.
    Hussain MZ; Ohtomo K; Kachi K; Uchiyama G; Itai Y
    Radiat Med; 1994; 12(1):1-5. PubMed ID: 8016397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual contrast magnetic resonance imaging with combined use of positive and negative contrast agent in human hepatocellular carcinoma.
    Suto Y; Shimatani Y
    Br J Radiol; 1995 Feb; 68(806):116-20. PubMed ID: 7735739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chondroitin sulfate iron colloid as an MR contrast agent for the hepatic reticuloendothelial system.
    Kato T; Suto Y; Matsuo T
    J Comput Assist Tomogr; 1993; 17(4):603-8. PubMed ID: 8392526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocellular carcinoma exhibiting a concentric structure of different histologic grades: evaluation by chondroitin sulfate iron colloid-enhanced MR imaging.
    Kamba M; Suto Y; Kodama F; Ohta Y; Kobayashi J; Horie Y; Kawasaki H
    J Magn Reson Imaging; 1996; 6(2):406-8. PubMed ID: 8859586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The Iron Content of Hepatocellular Carcinoma Associated Nodules: Study of Histopathology and MR Imaging].
    Liu D; Song B; Huang ZX; Wu B; Tang HH
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 May; 47(3):376-81. PubMed ID: 27468484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Superparamagnetic iron oxide-enhanced magnetic resonance imaging of hepatocellular carcinoma in rats].
    Liu X; Xu YK; Huang QL; Wu YK
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Dec; 22(12):1061-5. PubMed ID: 12480574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathomorphological study of Kupffer cells in hepatocellular carcinoma and hyperplastic nodular lesions in the liver.
    Tanaka M; Nakashima O; Wada Y; Kage M; Kojiro M
    Hepatology; 1996 Oct; 24(4):807-12. PubMed ID: 8855180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Iron oxide-enhanced MR imaging of hepatocellular carcinoma of woodchuck].
    Ohtomo K; Shiga J; Sasaki Y; Itai Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1991 Apr; 51(4):433-5. PubMed ID: 1648709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging of benign hypervascular hepatocellular nodules in alcoholic liver cirrhosis: differentiation from hypervascular hepatocellular carcinoma.
    Kobayashi S; Matsui O; Kamura T; Yamamoto S; Yoneda N; Gabata T; Terayama N; Sanada J
    J Comput Assist Tomogr; 2007; 31(4):557-63. PubMed ID: 17882031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
    Lee MH; Kim SH; Park MJ; Park CK; Rhim H
    AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Additional value of SPIO-enhanced MR imaging for the noninvasive imaging diagnosis of hepatocellular carcinoma in cirrhotic liver.
    Yoo HJ; Lee JM; Lee JY; Kim SH; Kim SJ; Han JK; Choi BI
    Invest Radiol; 2009 Dec; 44(12):800-7. PubMed ID: 19838119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of hepatic lesions (≤ 30 mm) with liver-specific contrast agents: a comparison between ultrasound and magnetic resonance imaging.
    Takahashi M; Maruyama H; Shimada T; Kamezaki H; Sekimoto T; Kanai F; Yokosuka O
    Eur J Radiol; 2013 Jan; 82(1):75-84. PubMed ID: 23116806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic performance of gadoxetic acid-enhanced liver MR imaging in the detection of HCCs and allocation of transplant recipients on the basis of the Milan criteria and UNOS guidelines: correlation with histopathologic findings.
    Lee DH; Lee JM; Baek JH; Shin CI; Han JK; Choi BI
    Radiology; 2015 Jan; 274(1):149-60. PubMed ID: 25203131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiating hepatocellular carcinoma from dysplastic nodules at gadobenate dimeglumine-enhanced hepatobiliary-phase magnetic resonance imaging.
    Gatto A; De Gaetano AM; Giuga M; Ciresa M; Siciliani L; Miele L; Riccardi L; Pizzolante F; Rapaccini GL; Gasbarrini A; Giuliante F; Vecchio FM; Pompili M; Bonomo L
    Abdom Imaging; 2013 Aug; 38(4):736-44. PubMed ID: 22986351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.